Эпизоды
-
This podcast explores the mOm Incubator, the importance of collaboration with healthcare professionals when designing medical devices, and the environmental impact of healthcare. Jonathan is joined by James Roberts, co-founder and CEO of mOm Incubators Ltd., a MedTech start-up on a mission to provide global access to high-quality healthcare. The pair discuss how the mOm incubator compares to traditional incubators, and the problems it solves.
Use the following timestamps to navigate this episode!
(00:00)-Introduction
(02:11)-Sparking interest in medical innovation
(04:11)-Navigating a medical device start-up
(07:03)-Unveiling the mOm incubator
(10:19)-The value of input from HCPs in device development
(13:04)-Delivering a simple yet low-risk device
(16:14)-Supplying mOm incubators to Ukraine
(20:16)-Considering the environmental impacts of medical devices
(23:30)-James’ proudest achievements
(26:58)-Looking to the future
(28:48)-Transport for London’s map of engineering icons
(31:09)-Three wishes for the future of healthcare
-
In this bonus episode of the EMJ podcast, Dr. Douglas Bradley is joining our host Dr Hannah Moir to discuss the recent outcomes from the ADVENT-HF randomised clinical trial. The discussion revolves around the relationship between heart failure and co-existing obstructive and/or central sleep apnoea. Dr Bradley considers the use of adaptive servo-ventilation (ASV), a non-invasive positive airway therapy, and provides insights on the trial outcomes. He also delves into the mechanism of action underlying ASV and discusses future developments in the sleep and cardiovascular space. This podcast has been funded by Philips.
-
Пропущенные эпизоды?
-
In this final episode of the series, the discussion focuses on the role of therapeutic drug monitoring and current practices, as well as how treatment decisions are made for patients refractory to anti-TNFs. The guests conclude by discussing the future of anti-TNFs and identifying the remaining gaps in the care of patients with inflammatory bowel disease.
This podcast series has been supported by Viatris, who were not involved in the creation of this content.
-
In this penultimate episode of the series on anti-TNFs for inflammatory bowel disease, our expert gastroenterologists discuss treatment options for difficult-to-treat Crohn’s disease and ulcerative colitis, including recent views and decision-making.
This podcast series has been supported by Viatris, who were not involved in the creation of this content.
-
In this episode, our expert gastroenterologists consider the importance of anti-TNF biosimilars as a treatment option for inflammatory bowel disease and the corresponding guideline recommendations.
This podcast series has been supported by Viatris, who were not involved in the creation of this content.
-
In this episode, our experts discuss the use of combination therapy involving anti-TNFs and immunomodulators, with a focus on the synergy and immunogenic effects, clinical trial outcomes, and the conversations that need to be had with patients.
This podcast series has been supported by Viatris, who were not involved in the creation of this content.
-
Our expert gastroenterologists continue their discussion of the side effects and risks of anti-TNFs, including infection, vaccine immunogenicity, and tuberculosis (TB) risk, as well as monitoring approaches.
This podcast series has been supported by Viatris, who were not involved in the creation of this content.
-
Our gastroenterology experts consider the patient's underlying comorbidities when making treatment decisions regarding anti-TNFs. They also evaluate the safety profile and risks, particularly for elderly patients
This podcast series has been supported by Viatris, who were not involved in the creation of this content.
-
In this episode, our experts discuss the recommended clinical anti-TNF treatments for inflammatory bowel disease in Europe and the USA and the patient factors that should be considered in patient decision-making.
This podcast series has been supported by Viatris, who were not involved in the creation of this content.
-
In this week’s episode, Jonathan and George Bakris, Comprehensive Hypertension Center, University of Chicago, Illinois, USA, chat about hypertension and renal denervation.
Use the following timestamps to navigate the content in this episode:
(00:00)-Introduction
(00:40)-Renal denervation Vs drugs in development for resistant hypertension
(06:06)-Get with the guidelines
(11:05)-Disparities in kidney disease incidence
(16:25)-Novel diabetes drugs
(19:42)-Remaining challenges in treating hypertension
(26:30)-Three wishes for healthcare
-
This podcast is supported by Medtronic.
This podcast episode, moderated by George Cooper, provides an exploration of the latest European Society of Hypertension (ESH) guidance on the use of renal denervation in uncontrolled hypertension management.
Atul Pathak, Princess Grace Hospital, Monaco, joins EMJ to offer key insights on renal denervation.
-
In this week’s episode, Jonathan and George Bakris, Comprehensive Hypertension Center, University of Chicago, Illinois, USA, discuss the role of music in medical practice, before diving into hypertension and ambulatory blood pressure monitoring.
Use the following timestamps to navigate the content in this episode:
(00:00)-Introduction
(02:47)-Hoosiers and music
(08:45)-Routes into medicine
(09:47)-Finding hypertension
(13:50)-Ambulatory blood pressure monitoring
(15:10)-White coat hypertension
(16:30)-Lowering your blood pressure
(18:09)-An innocent murmur
(18:59)-Markers of kidney and heart disease
(21:10)-Two most common causes of kidney disease
(23:18)-Arterial stiffness
-
In this episode, Jonathan chats with Mark Little, Consultant Interventional Radiologist at the Royal Berkshire NHS Foundation Trust, Reading, UK, where he has set up a large embolotherapy research group in addition to his clinical work. The two discuss everything from their shared passion for aviation to developments in prostate artery embolisation.
Use these timestamps to navigate our episode!
(00:00)-Introduction
(02:32)-What led Little to pursue a career in radiology
(09:01)-Prostate artery embolisation
(15:02)-Genicular artery embolisation
(21:40)-Uterine artery embolisation
(24:43)-The TARGET trial: using augmented reality to guide prostate cancer biopsy
(28:05)-The role of AI in radiology
(31:50)-Innovations on the horizon for interventional radiology
(35:23)-Three wishes
-
In this week’s episode, Jonathan is joined by Stephanie Hanna, a Research Fellow for the Diabetes Research and Wellness Foundation, in the Division of Infection and Immunity, at Cardiff University’s School of Medicine, Wales, UK. In this fascinating episode, the pair discuss all things diabetes, including immunotherapy, the future of diagnosis, and how to predict your diabetes risk.
Use the following timestamps to navigate the content in this episode:
(00:00)-Introduction
(01:22)-Getting into Type 1 diabetes (T1D)
(02:23)-Stages of T1D
(05:04)-Biomarkers of T1D
(07:01)-Phenotypic analysis of T and B-cells
(08:24)-Diabetes progression
(10:11)-Immunotherapy for T1D
(14:00)-Challenges in measuring immune response
(16:22)-Some thoughts on artificial intelligence
(18:11)-How to get involved in a study
(19:27)-Checking your own antibody status
(23:51)-Thyroid eye disease
(25:19)-Risks of overlooking T1D
(27:34)-Three wishes for the future of healthcare
-
Dr Teresa Amaral and Prof Mario Mandalà discuss: The typical patient for whom adjuvant therapy may be considered, and provide details on therapy choices. The long-term advantages of adjuvant treatments, and prospects for the use of biomarkers to help elucidate the best candidates for such therapies. The potential disadvantages of adjuvant therapy, and how more studies are needed to understand if these therapies can impact quality of life and fertility.
This content was fully funded by Novartis Pharma AG
-
In this bonus episode of the EMJ Podcast, host Brigitte Scott is joined by Ketta Lorusso, Humanitas University, Milan, Italy; and Rob Coleman, Vaniam Group, Chicago, Illinois, USA, who discuss key developments in endometrial cancer research that were presented in 2023.
This podcast was funded by a medical educational grant from GSK, with the purpose of enhancing the fundamental understanding of oncology specialists of key data and the latest advancements in endometrial cancer care. This content is not intended for US Healthcare Professionals.
-
This week’s episode focuses on innovations in diabetes technology, such as flash glucose monitoring and hybrid closed loop systems. Jonathan and Partha Kar, National Specialty Advisor in Diabetes for the National Health Service (NHS), UK, discuss promising innovations on the horizon, such as immunotherapy, as well as the importance of exercising caution on social media, and Partha’s Type 1 diabetes comic book.
Use the following timestamps to navigate the content in this episode:
(00:00)-Introduction
(02:40)-Partha’s love of comic books
(04:30)-Why diabetes?
(06:09)-Promoting technology in Type 1 Diabetes
(08:25)-Patient responsibility
(10:05)-Labelling patients with diabetes
(11:28)-Hybrid closed loop systems
(14:40)-Impact on the NHS and global healthcare
(16:04)-Pioneering the diabetes ‘super six’ model
(18:02)-Social media and combatting pseudoscience
(21:15)-Considering racism
(24:06)-Diabetes on ‘the big screen’
(27:31)-Game changing drugs for diabetes
(29:40)-Innovation: stem cells and immunotherapy
(31:24)-Partha’s three wishes for healthcare
(32:40)-Concluding remarks
- Показать больше